Brian Hubbard

Plus aucun poste en cours

53 ans

Consumer Services

Health Technology

Profil

Brian Hubbard worked at Dogma Therapeutics, Inc. from 2015 to 2021 as President, CEO, Secretary, Treasurer & Director.
From 2018 to 2024, Dr. Hubbard was Chief Executive Officer at Anji Pharmaceuticals, Inc. Dr. Hubbard also worked at Metsera, Inc. as Chief Scientific Officer from 2023 to 2025.
Dr. Hubbard completed undergraduate studies at The College of William & Mary and earned a doctorate from the University of Illinois.

Anciens postes connus de Brian Hubbard

Sociétés	Poste	Fin
Anji Pharmaceuticals, Inc. Anji Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of medicines for human genetics	Directeur Général	01/04/2024
Dogma Therapeutics, Inc. Dogma Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Developing oral PCSK9 inhibitors to treat high cholesterol and cardiovascular disease	Directeur Général	01/11/2021

Voir l'expérience en détail de Brian Hubbard

Formation de Brian Hubbard

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Brian Hubbard

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	4
The College of William & Mary The College of William & Mary Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Illinois University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Anji Pharmaceuticals, Inc. Anji Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of medicines for human genetics	Health Technology
Dogma Therapeutics, Inc. Dogma Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Developing oral PCSK9 inhibitors to treat high cholesterol and cardiovascular disease	Health Technology